Vincent O'Neill
Chief Tech/Sci/R&D Officer chez BIOXCEL THERAPEUTICS, INC.
Fortune : 15 251 $ au 31/03/2024
Profil
Vincent J.
O'Neill is currently a Member at The Royal College of Physicians.
He is also currently serving as EVP, Chief Medical & Product Development Officer at BioXcel Therapeutics, Inc. and as Senior VP, Chief Research & Development Officer at OnkosXcel Therapeutics LLC.
In the past, Dr. O'Neill worked as Group Director at Genentech, Inc. from 2009 to 2012.
He was also Director-Discovery Medicine at GSK Plc from 2006 to 2009.
Additionally, he served as Chief Medical Officer at Mirna Therapeutics, Inc. in 2016 and 2017.
Dr. O'Neill was Global Head-Personalized Medicine at Sanofi SA from 2012 to 2014, and Chief Medical Officer at Exosome Diagnostics, Inc. from 2014 to 2016.
Dr. O'Neill obtained his graduate and doctorate degrees from the University of Glasgow.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/04/2024 | 5 408 ( 0,02% ) | 15 251 $ | 31/03/2024 |
Postes actifs de Vincent O'Neill
| Sociétés | Poste | Début |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/07/2017 |
| The Royal College of Physicians | Corporate Officer/Principal | - |
OnkosXcel Therapeutics LLC
 OnkosXcel Therapeutics LLC Medical/Nursing ServicesHealth Services Part of BioXcel Therapeutics, Inc., OnkosXcel Therapeutics LLC operates as an oncology clinic. The private company is based in New Haven, CT. | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Vincent O'Neill
| Sociétés | Poste | Fin |
|---|---|---|
Mirna Therapeutics, Inc.
 Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Chief Tech/Sci/R&D Officer | 19/05/2017 |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | 01/05/2016 |
| Sanofi SA | Corporate Officer/Principal | 01/05/2014 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Director/Board Member | 01/06/2012 |
| GSK PLC | Corporate Officer/Principal | 01/01/2009 |
Formation de Vincent O'Neill
| University of Glasgow | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GSK PLC | Health Technology |
| BIOXCEL THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Sanofi SA | Health Technology |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Health Services |
OnkosXcel Therapeutics LLC
OnkosXcel Therapeutics LLC Medical/Nursing ServicesHealth Services Part of BioXcel Therapeutics, Inc., OnkosXcel Therapeutics LLC operates as an oncology clinic. The private company is based in New Haven, CT. | Health Services |
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Commercial Services |
